Greater Cannabis Company Executives
| GCAN Stock | USD 0.0005 0.0001 25.00% |
Analysis of Greater Cannabis' management performance can provide insight into the firm performance.
| Aitan Zacharin Chairman Pres, Chairman |
Greater |
Greater Cannabis Management Team Effectiveness
The company has return on total asset (ROA) of (0.3931) % which means that it has lost $0.3931 on every $100 spent on assets. This is way below average. Greater Cannabis' management efficiency ratios could be used to measure how well Greater Cannabis manages its routine affairs as well as how well it operates its assets and liabilities.Greater Cannabis Workforce Comparison
Greater Cannabis is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 127,504. Greater Cannabis adds roughly 1.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Greater Cannabis Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Greater Cannabis Price Series Summation is a cross summation of Greater Cannabis price series and its benchmark/peer.
Greater Cannabis Stakeholder
| Aitan Zacharin | Pres, Chairman | Profile |
About Greater Cannabis Management Performance
The success or failure of an entity such as Greater Cannabis often depends on how effective the management is. Greater Cannabis management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Greater management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Greater management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. The company was founded in 2014 and is based in Baltimore, Maryland. Greater Cannabis operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.
Greater Cannabis Workforce Analysis
Traditionally, organizations such as Greater Cannabis use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Greater Cannabis within its industry.Greater Cannabis Manpower Efficiency
Return on Greater Cannabis Manpower
| Revenue Per Employee | 12.6K | |
| Net Loss Per Employee | 602.2K |
Other Information on Investing in Greater Pink Sheet
Greater Cannabis financial ratios help investors to determine whether Greater Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Greater with respect to the benefits of owning Greater Cannabis security.